- Home
- PRTA vs ADSE Comparison
PRTA vs ADSE Comparison
Compare PRTA & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ADSE
- Stock Information
- Founded
- PRTA 2012
- ADSE 1980
- Country
- PRTA Ireland
- ADSE Ireland
- Employees
- PRTA N/A
- ADSE N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ADSE Industrial Specialties
- Sector
- PRTA Health Care
- ADSE Consumer Discretionary
- Exchange
- PRTA Nasdaq
- ADSE Nasdaq
- Market Cap
- PRTA 809.8M
- ADSE 807.1M
- IPO Year
- PRTA N/A
- ADSE N/A
- Fundamental
- Price
- PRTA $15.27
- ADSE $15.00
- Analyst Decision
- PRTA Buy
- ADSE Hold
- Analyst Count
- PRTA 9
- ADSE 1
- Target Price
- PRTA $54.57
- ADSE $14.00
- AVG Volume (30 Days)
- PRTA 396.4K
- ADSE 140.6K
- Earning Date
- PRTA 05-07-2025
- ADSE 04-29-2025
- Dividend Yield
- PRTA N/A
- ADSE N/A
- EPS Growth
- PRTA N/A
- ADSE N/A
- EPS
- PRTA N/A
- ADSE N/A
- Revenue
- PRTA $135,157,000.00
- ADSE $158,974,606.00
- Revenue This Year
- PRTA N/A
- ADSE $101.72
- Revenue Next Year
- PRTA $106.71
- ADSE $55.77
- P/E Ratio
- PRTA N/A
- ADSE N/A
- Revenue Growth
- PRTA 47.92
- ADSE 168.42
- 52 Week Low
- PRTA $11.70
- ADSE $9.52
- 52 Week High
- PRTA $30.86
- ADSE $16.35
- Technical
- Relative Strength Index (RSI)
- PRTA 54.26
- ADSE 52.58
- Support Level
- PRTA $13.89
- ADSE $13.80
- Resistance Level
- PRTA $16.16
- ADSE $15.07
- Average True Range (ATR)
- PRTA 1.14
- ADSE 0.67
- MACD
- PRTA 0.04
- ADSE -0.01
- Stochastic Oscillator
- PRTA 53.11
- ADSE 88.28
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.